Rifaximin Powder CAS No 80621-81-4

Active Pharmaceutical Ingredients Rifaximin is an effective treatment for bacterial intestinal infection, hepatic encephalopathy and inflammatory bowel disease. Acute bacterial intestinal infection is a common clinical disease of digestive system. If not treated in time and effectively, it can lead to irritable bowel syndrome in mild cases, dehydration, electrolyte disturbance, acidosis and even shock in severe cases, and seriously affect the quality of life. Currently, antibiotics are the main clinical treatment. Rifaximin is an oral, non-absorbable, locally acting antibiotic that has high antibacterial activity against a variety of gram-positive bacteria, gram-negative aerobic bacteria and anaerobic bacteria. Compared with other antibiotics such as levofloxacin and ciprofloxacin, Medicine Raw Material Rifaximin has no significant difference in the efficacy of bacterial intestinal infection. Rifampicin and ciprofloxacin Ming with the effectiveness of treatment of bacterial intestinal infection were 97.14% and 97.19% respectively, the cure rate of the treatment of acute bacterial intestinal infection, efficient, bacterial clearance rate and incidence of adverse reactions and levofloxacin and ciprofloxacin, is one of the clinical treatment of acute bacterial intestinal infection is safe and effective antimicrobials.

Rifaximin Powder CAS No 80621-81-4

[Product Name]: Rifaximin
[Apperance]: White Powder

[Specification]: 99%

[Test Method]: HPLC
[Storage]: Store in a cool, dry place and sealed container.

Used in pharmaceutical intermediates.

Our Hot Sales products are: Guanfacine HCL, Isoniazid 99%, Deoxycholic Acid, Tetrahydrocurcumin and so on.